Abstract
Introduction
Implantable cardioverter defibrillators (ICDs) are effective at reducing mortality in patients at high risk for sudden cardiac death (SCD) but can cause psychological distress and reduce quality of life (QOL). The full benefits of ICDs can only be achieved when the patient’s QOL and psychological status are maintained. We examined psychological status and QOL post ICD implantation; the relationship of psychological status to QOL; the relationship of time since implantation to psychological status and QOL; and the relationship of time since ICD implantation and age of patient to these variables.
Methods and Results
A cross-sectional self-administered assessment of QOL, depression, anxiety, demographic characteristics and cardiovascular health history of patients (n = 48) who had received ICDs within the past 10 years at an urban hospital. Patients who had ICDs for longer experienced worse depression and QOL. Patients who were younger had worse depression, anxiety, and QOL. The combination of anxiety, depression, age, and time since ICD implant significantly predicted overall QOL and the psychosocial and physical dimensions of QOL explaining 55.5, 54, and 34.9% of the variance, respectively.
Conclusion
Younger ICD patients are at highest risk for psychological distress and poor QOL. Longitudinal research would facilitate determination of the trajectory of changes in psychological status and QOL over the duration of the ICD experience.
Similar content being viewed by others
References
Moss, A. J., Hall, J., Cannon, D. S., Dawbert, J. P., Higgins, S. L., Kline, H., et al. (1996). Improved survival with implanted defibrillator on ventricular arrhythmia. New England Journal of Medicine, 335, 1933–1940.
Greenberg, H., Case, R. B., Moss, A. J., Brown, M. W., Carroll, E. R., & Andrews, M. L. (2004). Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II). Journal of the American College of Cardiology, 43(8), 1459–1465.
The Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial Executive Committe (1997). Are implantable cardioverter-defibrillators or drugs more effective in prolonging life? American Journal of Cardiology, 79(5), 661–663.
Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., et al. (2005). Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. New England Journal of Medicine, 352(3), 225–237.
Flemme, I., Bolse, K., Ivarsson, A., Jinhage, B., Sandstedt, B., Edvardsson, N., et al. (2001). Life situation of patients with an implantable cardioverter defibrillator: A descriptive longitudinal study. Journal of Clinical Nursing, 10, 563–572.
Newman, D. M., Dorian, P., Paquette, M., Sulke, N., Gold, M. R., Schwartzman, D. S., et al. (2003). Effect of an implantable cardioverter defibrillator with atrial detection and shock therapies on patient-perceived, health- realted quality of life. American Heart Journal, 145, 841–846.
Bainger, E. M., & Fernsler, J. I. (1995). Perceived quality of life before and after implantation of an internal cardioverter defibrillator. American Journal of Critical Care, 4, 36–43.
May, C. P., Smith, P. R., Murdock, C. J., & Davies, M. J. E. (1995). The impact of implantable cardioventricular defibrillator on quality of life. PACE, 18, 1411–1418.
Pelletier, D., Gallagher, R., Mitten-Lewis, S., McKinley, S., & Squire, J. (2002). Australian implantable cardiac defibrillator recipients: Quality-of-life issues. International Journal of Nursing Practice, 8, 68–74.
Kuhlkamp, V. (2002). Initial experience with an implantable cardioverter-defibrillator incorporating cardiac resynchronization therapy. Journal of the American College of Cardiology, 39(5), 790–797.
Hamilton, G. A., & Carroll, D. L. (2004). The effects of age on quality of life in implantable cardiverter defibrillator recipients. Journal of Clinical Nursing, 13, 194–200.
Arteaga, W. J., & Windle, J. R. (1995). The quality of life of patients with life-treatening arrhythmias. Archives of Internal Medicine, 155, 2086–2091.
Herbst, J. H., Goodman, M., Feldstein, S., & Reilly, J. M. (1999). Health-related quality-of-life assessment of patients with life threatening ventricular arrhythmias. PACE, 22, 915–926.
Schron, E. B., Exner, D. V., Yao, Q., Jenkins, L. S., Steinberg, J. S., Cook, J. R., et al. (2002). Quality of life in the antiarrhythmics versus implantable defibrillator trial: Impact of therapy and influences of adverse symptoms and defibrillator shocks. Circulation, 105, 589–594.
Strickberger, S. A., Hummel, J. D., Bartlett, T. G., Frumin, H. I., Schuger, C. D., Beau, S., et al. (2003). Amiodarone versus implantable cardioverter-defibrillator: Randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia—AMIOVIRT. Journal of the American College of Cardiology, 41, 1707–1712.
Duru, F., Buchi, S., Klaghofer, R., Mattmann, H., Sensky, T., Buddeberg, C., et al. (2001). How different from pacemaker patients are recipients of implantable cardioverter-defibrillators with respect to psychosocial adaptation, affective disorders, and quality of life? Heart, 85, 375–379.
Herrmann, C., von zur Muhen, F., Schaumann, A., Buss, U., Kemper, S., Wantzen, C., et al. (1997). Standardized assessment of psychological well-being and quality-of-life in patients with implanted defibrillators. Pacing and Clinical Electrophysiology, 20, 95–103.
Irvine, J., Dorian, P., Baker, B., O’Brien, B. J., Roberts, R., Gent, M., et al. for the CIDS Investigators. (2002). Quality of life in the Canadian Implantable Defibrillator Study (CIDS). American Heart Journal, 144, 282–289.
Chevalier, P., Verrier, P., Kirkorian, G., Touboul, P., & Cottraux, J. (1996). Improved appraisal of the quality of life in patients with automatic implantable cardioverter defibrillator: A psychometric study. Psychotherapy and Psychosomatics, 65, 49–56.
Wallace, R. L., Sears, S. F., Jr., Lewis, T. S., Griffis, J. T., Curtis, A., & Conti, J. B. (2002). Predictors of quality of life in long-term recipients of implantable cardioverter defibrillators. Journal of Cardiopulmonary Rehabilitation, 22, 278–281.
Thomas, S. A., Friedmann, E., & Kelley, F. J. (2001). Living with an implantable cardioverter-defibrillator: A review of the current literature related to psychosocial factors. AACN Clinical Issues, 12(1), 156–163.
Sears, S. F., Jr., Todaro, J. F., Lewis, T. S., Sotile, W., & Conti, J. B. (1999). Examining the psychosocial impact of implantable cardioverter defibrillators: A literature review. Clinical Cardiology, 22(7), 481–489.
Burke, J. L., Hallas, C. N., Clark-Carter, D., White, D., & Connelly, D. (2003). The psychosocial impact of the implantable cardioverter defibrillator: A meta-analytic review. British Journal of Health Psychology, 8(Pt 2), 165–178.
Beck, A. T., Stear, R. A., & Brown, G. K. (1996). The Beck depression inventory (2nd ed). Boston, MA: Houghton Mifflin.
Beck, A. T., Stear, R. A., & Garben, M. G. (1985). Psychometric properties of the Beck depression inventory: Twenty-five years of evaluation. Clinical Psychology Review, 8, 77–100.
Spielberger, C. D., Lushene, R. E., & Gorsuch, R. L. (1972). STAI manual. Palo Alto, CA: Consulting Psychology Press.
Frasure-Smith, N., Lesperance, F., & Talajic, M. (1995). The impact of negative emotions on prognosis following myocardial infarction: Is it more than depression? Health Psychology, 14(5), 388–398.
Bergner, M., Bobbitt, R. A., Pollard, W. E., Martin, D. P., & Gilson, B. S. (1976). The sickness impact profile: Validation of a health status measure. Medical Care, 14(1), 57–67.
Gilson, B. S., Gilson, J. S., Bergner, M., Bobbit, R. A., Kressel, S., Pollard, W. E., et al. (1975). The sickness impact profile. Development of an outcome measure of health care. American Journal of Public Health, 65(12), 1304–1310.
Bergner, M., Bobbitt, R. A., Carter, W. B., & Gilson, B. S. (1981). The sickness impact profile: Development and final revision of a health status measure. Medical Care, 19(8), 787–805.
Bergner, M., Bobbitt, R. A., Kressel, S., Pollard, W. E., Gilson, B. S., & Morris, J. R. (1976). The sickness impact profile: Conceptual formulation and methodology for the development of a health status measure. International Journal of Health Services, 6(3), 393–415.
Frasure-Smith, N., & Prince, R. (1985). The ischemic heart disease life stress monitoring program: Impact on mortality. Psychosomatic Medicine, 47, 431–445.
Thomas, S. A., Friedmann, E., Wimbush, F., & Schron, E. B. (1997). Psychological factors and survival in the cardiac arrhythmia suppression trial (CAST): A reexamination. American Journal of Critical Care, 6(2), 16–26.
Rozanski, A., Blumenthal, J. A., & Kaplan, J. (1999). Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation, 99(16), 2192–2217.
Ruo, B., Rumsfeld, J. S., Hlatky, M. A., Liu, H., Browner, W. S., & Whooley, M. A. (2003). Depressive symptoms and health-related quality of life: The heart and soul study. JAMA, 290(2), 215–221.
Gottlieb, S. S., Meenakshi, K., Friedmann, E., Einbinder, L., Katzen, S., Baker, B., et al. (2004). The influence of age, gender, and race on the prevalence of depression in heart failure patients. Journal of the American College of Cardiology, 43(9), 1542–1549.
Haveranek, E. P., Ware, M. G., & Lowes, B. P. (1999). Prevalence of depression in congestive heart failure. American Journal of Cardiology, 84, 348–350.
Skotzko, C. E., Krichten, C., Zietowski, G., Alves, L., Freudenberger, R., Robinson, S., et al. (2000). Depression in common and precludes accurate assessment of functional status in elderly patients with congestive heart failure. Journal of Cardiac Failure, 6, 300–305.
Murberg, T. A., & Bru, E. (2001). Social relationships and mortality in patients with congestive heart failure. Journal of Psychosomatic Research, 5, 521–527.
de Bruin, A. F., Diederiks, J. P., de Witte, L. P., Stevens, F. C., & Philipsen, H. (1994). The development of a short generic version of the sickness impact profile. Journal of Clinical Epidemiology, 47(4), 407–418.
Sears, S. F., Jr., Burns, J. L., Handberg, E., Sotile, W. M., & Conti, J. B. (2001). Young at heart: Understanding the unique psychosocial adjustment of young implantable cardioverter defibrillator recipients. Pacing and Clinical Electrophysiology, 24(7), 1113–1117.
DeBasio, N., & Rodenhausen, N. (1984). The group experience: Meeting the psychological needs of patients with ventricular tachycardia. Heart & Lung, 13(6), 597–602.
Badger, J. M., & Morris, P. L. (1989). Observations of a support group for automatic implantable cardioverter-defibrillator recipients and their spouses. Heart & Lung, 18(3), 238–243.
Molchany, C. A., & Peterson, K. A. (1994). The psychosocial effects of support group intervention on AICD recipients and their significant others. Progress in Cardiovascular Nursing, 9(2), 23–29.
Dickerson, S. S., Posluszny, M., & Kennedy, M. C. (2000). Help seeking in a support group for recipients of implantable cardioverter defibrillators and their support persons. Heart & Lung, 29(2), 87–96.
Ocampo, C. M. (2000). Living with an implantable cardioverter defibrillator: Impact on the patient, family, and society. Nursing Clinics of North America, 35(4), 1019–1030.
Duffey, J. S. (2004). The zapper. Retrieved from http://www.zaplife.org.
Dougherty, C. M., Pyper, G. P., & Frasz, H. A. (2004). Description of a nursing intervention program after an implantable cardioverter defibrillator. Heart & Lung, 33(3),183–190.
Cowan, M. J. (1997). Innovative approaches: A psychosocial therapy for sudden cardiac arrest survivors. In S. B. Dunbar, K. A. Ellenbogen, & A. E. Epstein (Eds.), Sudden cardiac death: Past, present, and future (pp. 371–386). Armonk, NY: Futura.
Cowan, M. J., Pike, K. C., & Budzynski, H. K. (2001). Psychosocial nursing therapy following sudden cardiac arrest: Impact on two-year survival. Nursing Research, 50(2), 68–76.
Author information
Authors and Affiliations
Corresponding author
Additional information
This research was partially supported by a grant from Medtronic. Dr. Thomas reports having received research funds from Medtronic. Dr. Gottlieb reports having received research grants from Medtronic and having served as a consultant to Guidant.
Rights and permissions
About this article
Cite this article
Friedmann, E., Thomas, S.A., Inguito, P. et al. Quality of life and psychological status of patients with implantable cardioverter defibrillators. J Interv Card Electrophysiol 17, 65–72 (2006). https://doi.org/10.1007/s10840-006-9053-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-006-9053-1